PubMed=2874115; DOI=10.1002/ijc.2910380218
Katoh T., Harada T., Morikawa S., Wakutani T.
IL-2- and IL-2-R-independent proliferation of T-cell lines from adult T-cell leukemia/lymphoma patients.
Int. J. Cancer 38:265-274(1986)

PubMed=2140233; DOI=10.1111/j.1440-1827.1990.tb01549.x
Nakano A., Harada T., Morikawa S., Kato Y.
Expression of leukocyte common antigen (CD45) on various human leukemia/lymphoma cell lines.
Acta Pathol. Jpn. 40:107-115(1990)

PubMed=10849313; DOI=10.1046/j.1440-1827.2000.01040.x
Nagasaki M., Morikawa S., Torii I., Zhang J., Morikawa K.
A human B-lineage dendritic cell line, HBM-Noda and its potential role in human T-cell leukemia/lymphoma virus type I infection.
Pathol. Int. 50:280-290(2000)

PubMed=15871724; DOI=10.1111/j.1440-1827.2005.01823.x
Nagasaki M., Zhang J., Morikawa S., Harada T., Nabika T., Tanaka Y.
Human leukocyte antigen-class II-negative long-term cultured human T-cell leukemia virus type-I-infected T-cell lines with progressed cytological properties significantly induce superantigen-dependent normal T-cell proliferation.
Pathol. Int. 55:264-272(2005)